Drugs / Vi-DT typhoid conjugate vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03527355 | Apr → Jul 2018 | typhoid fever | International Vaccine Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vi-DT typhoid conjugate vaccine | “Vi-DT typhoid conjugate vaccine” NCT03527355 ↗ |
| Known as | Vi-DT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03527355 ↗ |
| Modality | Vaccine | “we investigated the safety, immunogenicity and dose-scheduling of Vi-DT typhoid conjugate vaccine among children aged 6-23 months.” PMID 33150320 ↗ Sep 2020 |